Filing Flows › Nexgel (NXGL) › Q2 2026 › vs Q2 2025
Nexgel (NXGL) Q2 2026 vs Q2 2025 (year over year)
Nexgel's revenue rose $802K (+28%) from $2.9M in Q2 2025 to $3.7M in Q2 2026.
Nexgel, Q2 2026: revenue $3.7M (+28% year over year), operating margin -68.0%, net loss $3.6M, operating cash flow −$2.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3.7M | $2.9M | $802K | +28% |
| Net loss | $3.6M | $640K | $3.0M | +463% |
| Costs & expenses | $7.3M | $3.5M | $3.8M | +107% |
| Operating costs | $6.2M | $3.5M | $2.7M | +76% |
| Interest & other, net | $1.1M | $4K | $1.1M | 275× |
| Cost of revenue | $2.6M | $1.6M | $951K | +58% |
| Operating cash sources | $3.6M | $640K | $3.0M | +463% |
| Depreciation & amortization | $827K | $111K | $716K | +645% |
| Share-based compensation | $119K | $127K | −$8K | -6% |
| Working capital & other | $463K | −$5K | $468K | — |
| Cash used in operations | $2.2M | $407K | $1.8M | +440% |
| Net loss absorbed | $3.6M | $640K | $3.0M | +463% |
Questions
How much did Nexgel's revenue grow year over year in Q2 2026?
Nexgel's revenue rose $802K (+28%) from $2.9M in Q2 2025 to $3.7M in Q2 2026.